Solution structure and intramolecular exchange of methyl-cytosine binding domain protein 4 (MBD4) on DNA suggests a mechanism to scan for mCpG/TpG mismatches by Walavalkar, Ninad M. et al.
11218–11232 Nucleic Acids Research, 2014, Vol. 42, No. 17 Published online 02 September 2014
doi: 10.1093/nar/gku782
Solution structure and intramolecular exchange of
methyl-cytosine binding domain protein 4 (MBD4) on
DNA suggests a mechanism to scan for mCpG/TpG
mismatches
Ninad M. Walavalkar1, Jason M. Cramer2, William A. Buchwald1, J. Neel Scarsdale3 and
David C. Williams, Jr1,*
1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
27599, USA, 2Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA
23298, USA and 3Institute of Structural Biology and Drug Discovery, Center for the Study of Biological Complexity
and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA
Received April 25, 2014; Revised August 12, 2014; Accepted August 18, 2014
ABSTRACT
Unlike other members of the methyl-cytosine bind-
ing domain (MBD) family, MBD4 serves as a potent
DNA glycosylase in DNA mismatch repair specifically
targeting mCpG/TpG mismatches arising from spon-
taneous deamination of methyl-cytosine. The pro-
tein contains an N-terminal MBD (MBD4MBD) and a
C-terminal glycosylase domain (MBD4GD) separated
by a long linker. This arrangement suggests that the
MBD4MBD either directly augments enzymatic catal-
ysis by the MBD4GD or targets the protein to re-
gions enriched for mCpG/TpG mismatches. Here we
present structural and dynamic studies of MBD4MBD
bound to dsDNA. We show that MBD4MBD binds
with a modest preference for mCpG as compared
to mismatch, unmethylated and hydroxymethylated
DNA. We find that while MBD4MBD exhibits slow ex-
change between molecules of DNA (intermolecular
exchange), the domain exhibits fast exchange be-
tween two sites in the same molecule of dsDNA (in-
tramolecular exchange). Introducing a single-strand
defect between binding sites does not greatly re-
duce the intramolecular exchange rate, consistent
with a local hopping mechanism for moving along
the DNA. These results support a model in which the
MBD4MBD4 targets the intact protein to mCpG islands
and promotes scanning by rapidly exchanging be-
tween successive mCpG sites which facilitates repair
of nearby mCpG/TpG mismatches by the glycosylase
domain.
INTRODUCTION
DNA methylation involves enzymatic addition of a methyl
group at the C5 position of the symmetrically opposed cy-
tosine bases in a double stranded cytosine-guanosine se-
quence (CpG) and serves as a key epigenetic signal in
developmental and tissue type specific regulatory mech-
anisms such as gene silencing, chromatin modifications
and aberrant silencing of tumor suppressor genes in can-
cer (1). Central to these regulatory functions is a family
of proteins that selectively bind symmetrically methylated
CG dinucleotide sequences (mCpG) through a common
methyl-cytosine binding domain (MBD). The MBD was
first described as a ∼70 amino acid region in the MeCP2
protein (2) and subsequently identified by homology in
four additional proteins, MBD1–4 (3). MBD4 represents
a unique member of the MBD family in that it contains
intrinsic enzymatic activity provided by a C-terminal gly-
cosylase domain (MBD4GD) in addition to an N-terminal
MBD (MBD4MBD). The MBD4GD can remove thymine
or hydroxymethyluracil in mCpG/TpG and mCpG/hmUpG
double-stranded mismatches (3–7). The mCpG/TpG (or
mCpG/hmUpG) mismatch arises from hydrolytic deamina-
tion of a methyl-cytosine (or hydroxymethylcytosine) to
thymine (or hydroxmethyluracil) and represents one of the
more common sources of germ line and somatic DNA point
mutations.
The MBD4MBD binds in the major groove of DNA while
the MBD4GD binds the minor groove (8) and the two are
separated by a long spacer region (∼280 amino acids).
Since the two domains bind opposite faces of the DNA, the
MBD4MBD could selectively recognize a mCpG/TpG mis-
match and augment the enzymatic activity of the MBD4GD
at the same site - either by providing mismatch selectivity,
overall binding affinity or stabilizing the transition state. Al-
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ternatively the MBD4MBD could target the protein to re-
gions enriched for mCpG sites and allow the MBD4GD to
repair mismatches at nearby sites (4). Several pieces of ex-
perimental evidence favor the latter model. The MBD4GD
markedly distorts the DNA backbone which likely inhibits
simultaneous binding with the MBD4MBD (4,8). The iso-
lated MBD4GD maintains enzymatic activity in isolation
while addition of free MBD4MBD inhibits activity towards
a single mCpG/TpG mismatch site (9). MBD4GD orthologs
in invertebrates frequently lack an associated MBD (Sup-
plementary Table S1), again supporting the observation
that the MBD4GD does not require a MBD for function.
In the studies presented here, we determine the solution
structure of human MBD4MBD and show that it has a sim-
ilar overall architecture as exhibited by other MBD do-
mains. We show that MBD4MBD can bind methylated as
well as unmethylated, hydroxymethylated and mismatched
(mCpG/TpG) DNA with only modest preference for mCpG
(∼5-fold). Hence MBD4MBD does not show a strong pref-
erence for methylated DNA, which can be attributed to the
reorientation of a critical tyrosine residue. Based on these
observations, we hypothesized that dynamic intramolecu-
lar exchange by MBD4MBD could contribute to function by
allowing MBD4 to scan along CpG rich regions of chro-
matin. To test this hypothesis, we measured chemical ex-
change rates to compare intermolecular and intramolec-
ular exchange of MBD4MBD between two DNA bind-
ing sites. These studies show that intermolecular exchange
of MBD4MBD occurs in the nuclear magnetic resonance
(NMR) slow exchange time regime while intramolecular
exchange occurs in the NMR fast exchange time regime
and demonstrate that MBD4MBD preferentially exchanges
along the DNA between sequentially binding sites. They
represent the first example reported to date that demon-
strates rapid intramolecular exchange for the MBD family
of proteins. Together the data support a model in which the
MBD4MBD contributes to function by recruiting the pro-
tein to mCpG rich regions and rapidly scanning among the
mCpG sites.
MATERIAL AND METHODS
Protein expression and purification
The MBD4MBD (amino acids 80–148) was cloned and ex-
pressed with a hexahistidine tag and a thioredoxin fusion
in a modified pET32a vector (10). The expression vec-
tor was transformed into the BL21(DE3) Escherichia coli
strain, grown at 37◦C and induced with 1 mM isopropyl--
d-thiogalactopyranoside at an A600 ∼0.8. Induced bacteria
were harvested and lysed with the B-PER reagent (Thermo
Scientific). The soluble fraction was passed over a nickel-
sepharose column and protein was eluted with a step gradi-
ent of imidazole. The cMBD2MBD was expressed and puri-
fied as described previously. (11) For NMR analyses, uni-
form double (13C, 15N) and triple (13C, 15N, 2H) labeled
protein samples were generated by standard techniques and
the thioredoxin and hexahistidine fusion tags were removed
by thrombin cleavage overnight at room temperature. The
labeled protein was further purified by gel filtration over
a Superdex-75 column (GE Healthcare) followed by re-
verse phase chromatography over a SOURCE-15RPC col-
umn (GE Healthcare). For SPR analysis, the fusion protein
was purified over a nickel-sepharose column followed by
ion exchange chromatography over a MonoS 10/100 GL
(GE Healthcare) and size exclusion chromatography. The
Y109F mutation was introduced using the QuickChange R©
site-directed mutagenesis kit (Agilent) following the man-
ufacturer’s protocol. The final proteins for all experiments
were > 95% pure as estimated by SDS-PAGE analysis.
DNA purification
Complimentary DNA oligonucleotides were purchased
from integrated DNA technologies. Forward and reverse
oligonucleotides were dissolved in standard buffer (20 mM
Tris pH 8.0), mixed in equimolar concentrations, incubated
at >90oC for 10 min and cooled slowly to anneal. Subse-
quently, dsDNA was purified by ion exchange chromatog-
raphy on MonoQ 10/100 column (GE Healthcare). 3′ bi-
otinylated forward oligonucleotides (purchased from inte-
grated DNA technologies) were mixed with regular un-
labeled complimentary reverse oligonucleotides, annealed
and further purified using MonoQ 10/100 column for sur-
face plasmon resonance binding studies.
Surface plasmon resonance
Protein and DNA samples were prepared in standard buffer
(10 mM HEPES pH 6.5, 50 mM NaCl, 3 mM MgCl2, 0.1
mM EDTA, 1 mM DTT). Binding affinities of MBD do-
main with 3′ biotinylated DNA variants were determined
using a NLC sensor chip on ProteOnTM XPR36 (Bio-Rad).
Biotinylated dsDNAs were immobilized to the ligand chan-
nels of NLC chip using biotin-streptavidin chemistry until
the final response units were in the range of ∼100 RU, con-
trol channels were blocked without linking DNA. Various
concentrations of MBD4MBD were passed over the analyte
channels (at a flow rate of 30 l/min) in running buffer (10
mM HEPES pH 7.4, 50 mM NaCl, 3 mM MgCl2, 0.1 mM
EDTA, 1 mM DTT, 0.1%BSA, 0.005% polysorbate 20).
Data analysis, plotting and curve fitting were performed
with pro Fit software (QuantumSoft).
NMR spectroscopy
Purified protein was combined with 10% excess purified ds-
DNA and buffer exchanged into 10 mM NaPO4 pH 6.5,
1 mM dithiothreitol, 10% 2H2O and 0.02% sodium azide
and concentrated to 0.2–1 mM. NMR spectra from stan-
dard experiments for resonance assignments, distance and
torsional angle restraints were collected on a Bruker Avance
III 700 MHz instrument at 25oC. Data were processed us-
ing NMRPipe (12) and analyzed with CcpNmr (13). Resid-
ual dipolar couplings were measured for complexes contain-
ing 2H,13C,15N labeled protein using standard IPAP exper-
iments and samples aligned by adding ∼12 mg/ml pf1 bac-
teriophage (Asla Biotech, Ltd.) (14,15).
Structure calculations
The solution structure was determined for MBD4MBD
bound to a dsDNA fragment with a central symmetri-
cally methylated mCpG dinucleotide. Initially, a complete
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NMR dataset was collected for MBD4MBD bound to a
17 bp fragment derived from the p16INK4a promoter as
described previously (16). These data revealed significant
line-broadening for residues at the protein–DNA interface
which suggested dynamic exchange between binding modes.
To limit intramolecular exchange, a second dataset was col-
lected for MBD4MBD bound to a 10 bp fragment of ds-
DNA (GGATmCGGCTC) identical to that in the solution
structure of cMBD2 (11). This dataset showed a significant
reduction of line-broadening and was used for all subse-
quent structure calculations and analyses. The structure was
calculated by standard simulated annealing techniques us-
ing the Xplor-NIH software package (17) and minimized
against a target function that included Nuclear Overhauser
Effect (NOE)-derived interproton distances, torsion angles
and residual dipolar couplings restraints; a quartic van der
Waals repulsion term for the non-bonded contacts (18); a
torsion angle data base potential of mean force (19) and a
radius of gyration restraint to ensure optimal packing (20).
Backbone torsion angle restraints were derived from chem-
ical shift indexing as implemented by TALOS-N software
(21,22). 3JN-C and 3JCO-C coupling constants were measured
to determine a limited number of sidechain torsion an-
gle restraints. Hydrogen bond distance and angle restraints
were incorporated for regions of secondary structure as pre-
dicted by TALOS-N and confirmed by characteristic NOE
crosspeak patterns. Based on chemical shift changes ob-
served for Arg97 15N (as described previously (11,16)), hy-
drogen bond distance and angle restraints between Arg97
H/HH21 and Asp107 O1/O2, respectively, were incorpo-
rated in structure calculations.
The DNA assignments and NOE restraints were derived
from double filtered (13C,15N) homonuclear NOE experi-
ments and by comparison with previous spectra and as-
signments for cMBD2 bound to the same DNA (11). As-
signments of the key 5-methyl-cytosine H5 protons were
confirmed by the presence of strong NOEs between Thy204
H6 and both Thy204 H5 and mCyt205 H5. In addition to
the NOE restraints, hydrogen bond distance and planarity
restraints as well as B-form DNA backbone torsion an-
gle restraints were incorporated into structure calculations.
Intermolecular protein–DNA NOEs were derived from an
isotope-filtered 3D 13C HMQC-NOESY spectrum. As was
described previously (11), hydrogen bond distance and an-
gular restraints were incorporated between Arg97/Arg109
NH2 and Gua206/Gua216 O6 and N7, respectively, in the fi-
nal simulated annealing calculations.
Molecular dynamics simulations
A B-form methylated DNA structure comprising the 10
bp sequence with three additional cytosine bases on each
end for added stability was generated using the 3D-DART
webserver (23) and Visual Molecular Dynamics software
(24). The DNA and preliminary MBD4MBD structures were
docked and solvated in a box with 10 Å of TIP3P water
surrounding the complex and 75 mM NaCl. All dynamics
simulations were carried out using NAMD 2.9 (25) and the
CHARMM27 (26) force field. The system was equilibrated
with two rounds of preparative constant number, volume,
and temperature (NVT) simulations. In the first round, 5000
steps of minimization were followed by 30 ps of dynamics ps
at 300 K with all atoms of the protein–DNA complex held
rigid. In the second round, the same protocol was used ex-
cept that the rigid restraints on the protein–DNA complex
were replaced by a harmonic restraint (5 kcal/mol/Å) ap-
plied to the backbone atoms of the protein–DNA complex.
Finally a 1 ns preparative constant number, pressure, and
temperature (NPT) simulation was carried out on the sys-
tem using a Langevin piston barostat (27,28) with a target
pressure of 1.01325 bar, a decay period of 100 fs and a pis-
ton temperature of 300 K followed by 40 ns of unrestrained
NPT dynamics.
Nz-exchange spectroscopy
Two separate samples comprising 2H,15N labeled
MBD4MBD at a final concentrations of 200 M and
333 M were combined with a mixture of wild-type and
inverted 10 bp methylated DNA at final molar ratios of
1:2:2 (protein:wild-type DNA:inverted DNA). A series
of 2D 1H-15N TROSY based Nz-exchange spectra (29)
were collected with total exchange delays of 11.9, 14.3,
16.8, 21.8, 29.3, 36.8, 49.3, 61.8, 111.8 and 211.8 ms.
The data were processed as pseudo-3D spectra using a
Lorentz-to-Gaussian window function in both dimen-
sions and the spectra fit using an automated lineshape
fitting algorithm within the NMRPipe software (12). The
intensities for the auto and exchange crosspeaks were fit
to four coupled equations describing chemical exchange
in the slow exchange limit (30) using pro Fit software
(Quantum Soft). For comparison, two samples of 1H,15N
labeled cMBD2MBD at final concentrations of 185 M and
370 M were combined with a mixture of wild-type and
inverted 10 bp methylated DNA at final molar ratios of
1:2:2 (protein:wild-type: inverted DNA). A series of 2D
1H-15N Nz-exchange spectra (non-TROSY versions) were
collected and analyzed in a similar manner.
RESULTS
Solution structure of MBD4MBD bound to methylated DNA
We determined the solution structure of the methyl binding
domain from human MBD4 (amino acids 80–148) bound
to a 10 bp DNA fragment containing a central symmetri-
cally methylated mCpG dinucleotide. This 10 bp DNA was
derived from the chicken  globin promoter and was used
previously in structural studies of cMBD2MBD (11) (Ta-
ble 1). The structure was well determined with an overall
root mean square deviation (RMSD) from the mean for the
backbone of the MBD4MBD = 0.7 ± 0.1 Å and for the com-
plex = 1.2 ± 0.3 Å (Table 2, Figure 1a). The structure com-
prises a 3-strand -sheet that extends down and across the
major groove and includes many of the DNA contacts (Fig-
ure 1b). The loop connecting the first two -strands shows
conformational heterogeneity within the ensemble of struc-
tures, which is similar to that seen for MBD3 (16). An -
helix follows the -sheet which is similar in length to the
same helix in MeCP2 and longer than for MBD1, cMBD2
and MBD3 (Figure 1c). The length of this helix reflects a
four amino acid insertion common to both MeCP2 and
MBD4, which results in a larger hydrophobic core.











Figure 1. Solution structure of MBD4MBD bound to methylated DNA. (a) A best-fit superimposition stereo cartoon diagram depicts the twenty calculated
structures of the MBD4MBD (yellow) and DNA (green) with key interacting protein residues shown as stick diagrams. (b) A cartoon diagram depicts the
lowest energy structure of MBD4MBD (yellow) and DNA (green) with key interacting protein residues shown as stick diagrams. (c) A best-fit superimposi-
tion cartoon diagram of the MBD4MBD (yellow), MeCP2MBD (blue) and cMBD2MBD (green) shows that the C-terminal -helix is longer in MeCP2 and
MBD4 as compared to cMBD2. Horizontal bars below the diagram highlight the relative lengths of this -helix in each. (d) An expanded mixed rendering
diagram shows critical interactions involved in DNA binding with key residues shown as sticks and potential hydrogen bonds highlighted with yellow
dashed lines. Note that Tyr109 points away from DNA, which differs from other MBD proteins.
Table 1. Oligonucleotide sequences
Oligonucleotide Sequence
mCpG (17 bp) 5′-GAGGCGC TmCGG CGGCAG-3′
3′-CTCCGCG AGmCC GCCGTC-5′
CpG (17 bp) 5′-GAGGCGC TCGG CGGCAG-3′
3′-CTCCGCG AGCC GCCGTC-5′
hmCpG (17 bp) 5′-GAGGCGC ThmCGG CGGCAG-3′
3′-CTCCGCG AGhmCC GCCGTC-5′
mCpG/TpG (17 bp) 5′-GAGGCGC TmCGG CGGCAG-3′
3′-CTCCGCG AGTC GCCGTC-5′
mCpG (10 bp) 5′-GGA TmCGG CTC-3′
3′-CCT AGmCC GAG-5′
Inverted (10 bp) 5′-GGA CmCGA CTC-3′
3′-CCT GGmCT GAG-5′
Tandem (30 bp) 5′-CACGGA TmCGG CT CCCC CGAG TmCGG TCCCGC-3′
3′-GTGCCT AGmCC GA GGGG GCTC AGmCC AGGGCG-5′
Tandem nicked (30 bp) 5′-CACGGA TmCGG CT CCCC CGAG TmCGG TCCCGC-3′
3′-GTGCCT AGmCC GA GG - - GCTC AGmCC AGGGCG-5′
Tandem (20 bp) 5′-GGA TmCGG CTC GGA CmCGA CTC-3′
3′-CCT AGmCC GAG CCT GGmCT GAG-5′
Only a relatively few intermolecular NOEs between pro-
tein and DNA could be measured which is consistent with
an interface dominated by solvent mediated interactions
and few base specific contacts (Figure 1d). The base spe-
cific interactions primarily involve two arginine side chains
(Arg97 and Arg119) that establish bidentate hydrogen bonds
with the symmetrically related bases of the CpG dinu-
cleotide. A highly conserved aspartate (Asp107) makes side
chain hydrogen bonds and stabilizes Arg97 in the appro-
priate conformation. Unlike other MBD proteins, a criti-
cal tyrosine residue (Tyr109) no longer points towards the
methyl group of mCyt, instead this residue points towards
the phosphate backbone and solvent. The latter observa-
tion is confirmed both by NOEs detected between Tyr109
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Table 2. NMR and refinement statistics
Protein Nucleic acid
NMR distance and dihedral constraints
Distance restraints
Total NOE 487 115
Intraresidue 105 68
Inter-residue 382 47
Sequential (|i − j| = 1) 149 30
Non-sequential (|i − j| > 1) 233 17
Hydrogen bonds 18 37
Hydrogen bonds protein–nucleic acid 4
Protein–nucleic acid intermolecular 12









RDC Q% (number of constraints)
NH 1.0 ± 0.4 (37)
Structure statistics
Violations (mean and s.d. for the complex)
Distance constraints (Å) 0.035 ± 0.004
Dihedral angle constraints (o) 0.34 ± 0.04
Maximum dihedral angle violation (o) 2.2
Maximum distance constraint violation (Å) 0.39
Deviations from idealized geometry
Bond lengths (Å) 0.0027 ± 0.0002
Bond angles (o) 0.546 ± 0.008
Impropers (o) 0.32 ± 0.01
Average pairwise RMS deviationa (Å)
Protein
Heavy 1.3 ± 0.2
Backbone 0.7 ± 0.1
DNA
Heavy 0.3 ± 0.1
Backbone 0.5 ± 0.1
Complex
Heavy 1.4 ± 0.3
Backbone 1.2 ± 0.3
Ramachandran plot summarya
Most favored regions 94.0%
Additionally allowed regions 5.9%
Generously allowed regions 0.1%
Disallowed regions 0.0%
aPairwise RMS deviation and Ramachandran plot summary was calculated among 20 refined structures for structured residues (amino acids 86–140 of
MBD4MBD and base pairs 202–212 of DNA).
and Val93/Lys95 as well as J-coupling measurements for the

 1 torsion angle of Tyr109 (JC’C ≈ 0 Hz). As we previously
described in the solution structure of cMBD2:dsDNA,
base specific intermolecular NOEs between MBD4MBD and
DNA indicate that the protein binds predominantly in a
single orientation on DNA. Distinct NOEs between Arg97
and mCyt205 and between Arg119 and mCyt215 can only be
satisfied by a single orientation on the DNA. In addition,
we detected intermolecular NOEs between Thr102 and both
Gua206 and Gua207 that confirm this orientation.
Molecular dynamics simulations of the MBD4MBD:dsDNA
complex
To further characterize the MBD4MBD:DNA interface and
better understand the orientation preference of Tyr109,
we carried out molecular dynamics simulations of the
MBD4MBD:dsDNA complex. The two key arginine residues
Arg97 and Arg119 established persistent bidentate hydrogen
bonds with the symmetrically related guanosine bases of
the CpG dinucleotide Gua206 and Gua216, respectively (Fig-
ure 2a), which is consistent with the experimental solution
structure. Likewise the side chain of Asp107 also forms per-
sistent bidentate hydrogen bonds with Arg97 (Figure 2a).
Plots of distances between hydrogen bond donors and ac-
ceptors for these interactions show that these hydrogen
bonds are established early and broken only intermittently
during the simulation (Figure 2c). In addition, Tyr109 main-
tains a gauche(+) 
 1 torsion angle throughout the sim-
ulation as opposed to the gauche(−) 
 1 torsion angle in
MeCP2 (Figure 2b). As can be seen in Figure 2b, Tyr109 fits
within a hydrophobic pocket formed by the side chains of
Val93, Lys95, Ile111 and Lys117. The conformation of these
side chains is stabilized by interactions between the lysine -
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Arg119 NH1 - Gua216 N7
Arg119 NH2 - Gua216 O6
Arg97 Nε - Asp107 Oδ1
Arg97 NH1 - Asp107 Oδ2
Arg97 NH1 - Gua206 O6
Arg97 NH2 - Gua206 N7
Arg105 NH1 - Gua213 O6
Arg105 NH2 - Gua213 N7
Figure 2. Molecular dynamics simulation highlights critical MBD4MBD–DNA interactions. (a-b) Expanded mixed rendering diagrams from the final frame
of a 40 ns molecular dynamics simulation show key interactions with DNA. Basic specific interactions between arginine residues and DNA are highlighted
in (a) including the potentially orienting interaction between Arg105 and Gua213. Methyl groups of mCyt are depicted as translucent spheres while potential
hydrogen bonds are shown as yellow dashed lines. Residues that stabilize the gauche(+) 
 1 torsion angle of Tyr109 are highlighted in (b) with potential
hydrogen bonds to the phosphate backbone of DNA shown as yellow dashed lines. For comparison the orientation of the equivalent tyrosine in MeCP2
(Tyr123) is shown in blue. (c) Distances between specific heavy atoms are plotted every 10 ps of the 40 ns molecular dynamics simulation. These distances
are shown for potential bidentate hydrogen bonds between Arg119 and Gua216, Arg97 and Asp107, Arg97 and Gua206 and Arg105 and Gua213.
amino groups and the phosphate backbone of DNA as well
as between the tyrosine hydroxyl and the phosphate back-
bone of DNA.
We previously showed that Lys32 of cMBD2MBD makes
base specific interactions with Gua107 which contributes
to the binding affinity and preferred orientation on an
mCpGG trinucleotide (11). Since MBD4MBD binds in a sim-
ilar orientation on this same DNA sequence, we hypothe-
sized that the equivalent residue, Arg105, would make sim-
ilar base specific interactions. During the molecular dy-
namics simulation, the side chain of Arg105 reaches across
the major groove to form intermittent bidentate hydrogen
bonds with Gua213 (Figure 2b). This base specific inter-
action differs from that observed cMBD2MBD in that the
guanosine is on the opposite strand and one base removed
from the CpG dinucleotide while the base specific interac-
tion identified in cMBD2 involved Gua107, which imme-
diately follows the CpG dinucleotide. The interaction be-
tween Arg105 and Gua213 helps explain the preferred orien-
tation on DNA since Ade203, which has only one hydrogen
bond acceptor, occupies the equivalent position to Gua213 if
MBD4MBD were to bind in the reverse orientation. A differ-
ent and palindromic DNA sequence was used in a recently
deposited crystal structure of human MBD4MBD such that
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Arg105 hydrogen bonds to O4 of thymidine immediately fol-
lowing the CpG dinucleotide (PDB ID: 4LG7). In contrast,
lysine occupies the equivalent position in a crystal structure
of mouse MBD4MBD which interacts with the phosphate
backbone instead of making a base specific interaction (31).
Comparison with other MBDs
Structural information is now available for most of the
MBD family of proteins (MeCP2, MBD1–4). The crystal
structure of MeCP2MBD (32) and the NMR structures of
MBD1MBD (33), MBD2MBD (11) and MBD3MBD (16) have
previously been reported. More recently the crystal struc-
tures of mouse MBD4MBD bound to methylated, hydrox-
ymethylated and mismatch DNA were reported (31) and a
crystal structure of human MBD4MBD bound to methylated
DNA was deposited in the RCSB (PDB ID: 4LG7) by the
Structural Genomics Consortium Toronto. All of the MBD
structures show similar folds and demonstrate that the key
DNA contacting residues are largely conserved and form
a similar DNA recognition interface (Figure 1). The back-
bone RMSD between the solution structure of MBD4MBD
and other MBDs is as follows: MeCP2 - 1.7 Å; MBD1 - 2.0
Å; cMBD2 - 2.5 Å; MBD3 - 2.3 Å; human MBD4MBD crys-
tal structure - 1.5 Å; mouse MBD4MBD (excluding a small
C-terminal helix) bound to mCpG - 1.8 Å, hmCpG - 1.8
Å, mCpG/TpG mismatch - 1.8 Å; and mouse MBD4MBD
bound to both a mCpG/TpG mismatch and a non-specific
complex - 1.6 Å. The MBD family can be divided into two
groups (MBD1/2/3 and MeCP2/MBD4) reflecting the four
amino acid insertion described above. Because of this in-
sertion, both MBD4MBD and MeCP2MBD contain a longer
C-terminal -helix that provides a larger hydrophobic core.
Consistent with this observation, both MeCP2 (34) and
MBD4 adopt a regular folded structure in isolation as op-
posed to MBD2 and MBD3 which undergo a disorder to
order transition upon binding DNA (11,16). 2D 15N-HSQC
spectra of the isolated MBD4MBD (not bound to DNA) con-
tains sharp well-dispersed peaks indicative of a folded do-
main while that of cMBD2 does not (Supplementary Figure
S1).
A few changes at the protein–DNA interface potentially
explain binding affinity and methylation selectivity differ-
ences among the MBDs. Both mouse and human crystal
structures of MBD4MBD as well as our solution structure
of MBD4 show the same reorientation of Tyr109, which
plays a critical role in methylation specific DNA binding
for MBD2 and MBD3. As described by Otani et al. (31),
this change in Tyr109 conformation opens up a large solvent
accessible cavity at the protein–DNA interface. In addition,
this change removes one of the key interactions that drives
binding selectivity for methylated DNA which indicates that
MBD4MBD would not show the same level of methylation
selectivity as cMBD2MBD and mutating this Tyr109 would
not reduce binding affinity and selectivity as seen with other
MBDs. We test both of these hypotheses in the binding anal-
ysis reported below.
One of the more notable differences between the crystal
structures of mouse MBD4MBD reported by Otani et al. (31)
and the solution structure reported here is that a small C-
terminal helical region adopts an extended conformation
and swaps positions with symmetry related molecules in
three of the crystal structures (PDB IDs: 3VXX, 3VXV and
3VYB). This same region adopts the more typical compact
monomeric fold in the solution structure reported here as
well as in the fourth mouse MBD4MBD(PDB ID: 3VYQ)
and human MBD4MBD crystal structures. To confirm the
relative orientation of this region, we fit the residual dipo-
lar couplings measured for MBD4MBD in solution to the
crystal structure of mouse MBD4MBD bound to methy-
lated DNA using singular value decomposition as imple-
mented by PALES software (35). If we included the en-
tire dataset, the quality of fit was poor (Q = 78.9%) but if
we excluded values from the C-terminal helical region, the
fit markedly improves(Q = 26.7%). Hence residual dipolar
coupling measurements confirm the monomeric fold in so-
lution which supports the interpretation by Otani et al. (31)
that apparent dimerization of mouse MBD4MBD reflects a
crystal lattice induced artifact.
MBD4MBD preferentially binds methylated over mismatch,
hydroxymethylated and unmethylated DNA
The binding affinity of MBD4MBD for modified and un-
modified 17 bp oligonucleotides (Table 1) was determined
by surface plasmon resonance (Figure 3) and the results
are summarized in Table 3. Although the overall affinity for
DNA is relatively weak, MBD4MBD shows a modest prefer-
ence for methylated DNA (KD ∼6.4 M) over mCpG/TpG
mismatch (KD ∼11.5 M), hydroxymethylated (KD ∼14.2
M) and unmethylated DNA (KD ∼17.2 M). These find-
ings are similar to those reported by Hashimoto et al. (36)
for human MBD4MBD and suggest that the reorientation
of Tyr109 reduces the overall affinity and methylation se-
lectivity. Hence MBD4MBD can bind a variety of modi-
fied CpGs with comparable affinity and only modest se-
lectivity for mCpG. Based on these observations, we hy-
pothesized that a Y109F mutation in MBD4MBD would
not affect binding affinity to the same degree as observed
for other MBDs (16,37,38). As shown in Figure 3 and Ta-
ble 3, MBD4MBD(Y109F) binds methlylated DNA with sim-
ilar overall affinity (KD ∼7.9 M) and relative selectiv-
ity over mCpG/TpG mismatch (KD ∼14.0 M), hydrox-
ymethylated (KD ∼16.0 M) and unmethylated (KD ∼19.6
M) DNA. These findings contrast with the large reduc-
tion in binding affinity and reduction in methylation selec-
tivity associated with the same modification in cMBD2 and
the differences in binding specificity between MBD3 and
MBD2 (16,37,38).
We previously showed that the 15N, 1H chemical shifts of
select residues in the MBD reflected a distribution between
CpG specific and non-specific binding modes of MBD2
and MBD3. Hence we compared the chemical shifts of
the same residues in MBD4MBD. As described previously
for MBD2, the 1H chemical shift of Arg97 is shifted far
downfield to ∼9.6 ppm when bound to mCpG (Supplemen-
tary Figure S2), which is consistent with stabilization of the
side chain hydrogen bond with Asp107. When MBD4MBD
binds unmethylated DNA, this peak shifts ∼0.8 ppm up-
field to ∼8.8 ppm and when bound to hydroxymethylated
DNA, the same peak falls between the two extrema at
∼9.1 ppm. Likewise, the 15N chemical shift of Gly100 is
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Table 3. DNA binding affinity
KD (M) Rmax X2 (10−4)
MBD4MBD-mCpG 6.4 ± 1.5 0.74 34
MBD4MBD-TpG 11.5 ± 1.2 0.59 2.3
MBD4MBD-CpG 17.2 ± 2.0 0.91 3.5
MBD4MBD-hmCpG 14.2 ± 1.9 0.72 3.9
MBD4MBD(Y109F)-mCpG 7.9 ± 1.6 0.63 14
MBD4MBD(Y109F)-TpG 14.0 ± 1.4 0.51 1.0
MBD4MBD(Y109F)-CpG 19.6 ± 3.5 0.76 3.5




































Figure 3. MBD4MBD shows a modest binding preference for methy-
lated DNA. Steady state response curves are shown for surface plasmon
resonance analyses of wild-type MBD4MBD (upper panel) and mutant
MBD4MBD(Y109F) (lower panel) binding to methylated (green), mismatch
(blue), unmethylated (purple) and hydroxymethylated (green) DNA. Both
wild-type and mutant MBD4MBD show a similar modest preference for
methylated DNA.
shifted far upfield when bound to mCpG (Supplementary
Figure S2) and is shifted downfield by ∼1 ppm when bound
to unmethylated and hydroxymethylated DNA. Interest-
ingly the peak for Gly100 15N-1H is shifted upfield while the
peak for Arg97 15N-1H is broadened and not observed
when bound to mCpG/TpG mismatch. Together these find-
ings support the relative binding affinities for the differ-
ent modified substrates and indicate that, like MBD3 and
MBD2, MBD4MBD distributes between CpG specific and
non-specific binding modes when bound to DNA.
Intermolecular and intramolecular exchange of MBD4MBD
between methylated sites
We previously established that exchanging the bases imme-
diately flanking the mCpG causes the MBD2MBD to re-
verse orientation on the DNA (11). In doing so, we noted
that binding to the inverted sequence led to chemical shift
changes in select backbone amide (15N, 1H) resonances. 2D
15N-1H HSQC spectra of 15N-MBD4MBD also show distinct
chemical shifts for selected reporter residues, Arg105 and
Phe106, (Figure 4) when bound to DNA with the central four
bases in the inverted orientation (Table 1). This observation
allows us measure chemical exchange between these closely
related mCpG binding sites by Nz-exchange NMR spec-
troscopy (29). When bound to a mixture of the wild-type
and inverted sequences (1:2:2 molar ratio of MBD4MBD,
wild-type and inverted DNA), two distinct peaks were ob-
served for these same reporter residues (Figure 4a and b)
which indicate that MBD4MBD exchanges slowly on the
NMR timescale between two DNA molecules.
To measure the intermolecular exchange rate, we col-
lected 1H-15N TROSY based Nz-exchange spectra (29) with
exchange delays ranging from 11.9–211.8 ms. As can be seen
in Figure 4b exchange crosspeaks, AB and BA (which rep-
resent exchange from wild-type to inverted or inverted to
wild-type sequences, respectively) buildup with increasing
delay. The intensities of the auto and exchange peaks were
fit to four coupled equations describing chemical exchange
in the slow exchange limit (Figure 4c) (30). These data show
that at 200 M protein and 800 M total DNA intermolec-
ular exchange of MBD4MBD occurs with a mean lifetime
of ∼40 ms. Increasing the protein and total DNA concen-
tration to 333 M and 1.33 mM, respectively, shortens the
mean lifetime to ∼23 ms as would be expected for inter-
molecular exchange.
To test whether MBD4MBD exchanges more rapidly be-
tween two binding sites in the same DNA molecule, we
bound MBD4MBD to a 30 bp oligonucleotide containing
both wild-type and inverted mCpG sequences separated by
12 bp (Table 1) at a protein concentration of 200 M and
total mCpG binding site concentration of 800 M. A 2D
TROSY 15N-HSQC of this complex no longer showed dis-
tinct peaks for the two bound states (Figure 5b). Instead
the spectrum contains only a single peak for Arg105 located
at approximately 62% of the distance between the peaks
for same residue in the wild-type and inverted DNA com-
plexes. Assuming the chemical shifts for MBD4MBD bound
to either the wild-type or inverted sequences do not change
11226 Nucleic Acids Research, 2014, Vol. 42, No. 17
Figure 4. MBD4MBD exchanges between molecules of DNA on the slow NMR timescale. (a) 2D 1H-15N HSQC spectra of MBD4MBD bound to wild-
type (black) and inverted (red) DNA sequences show that the chemical shifts for Arg105 and Phe106 differ between the two complexes. (b) 2D 1H-15N
Nz-exchange spectra of MBD4MBD bound to a 1:1 mixture of wild-type and inverted (10 bp) sequences shows two distinct peaks for Arg105 and Phe106
which represent between binding to the different DNA sequences. The exchange crosspeaks, AB and BA, increase in intensity with increasing exchange
delay (2.5 and 25 ms) and represent intermolecular exchange between DNA molecules. (c) The intensities for auto (AA and BB) and exchange (AB and
BA) crosspeaks for Arg105 (upper panels) and Phe106 (lower panels) were fit to four coupled equations to determine the rate of intermolecular exchange at
200 M (left panels) and 333 M (right panels) MBD4MBD concentration.
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Figure 5. MBD4MBD exchanges between methylated sites in the same molecule of DNA on the fast NMR timescale. (a) A diagram depicting slow
intermolecular and fast intramolecular exchange by MBD4MBD. (b) 2D 1H-15N TROSY HSQC spectra of MBD4MBD bound to methylated wild-type
and inverted (10 bp) DNA (red), tandem (30 bp) DNA (blue) and tandem nicked (30 bp) DNA (green) show that MBD4MBD more rapidly exchanges
between sites in the same molecule of DNA. The spectra show only a single crosspeak for Arg105 (left panel) when bound to DNA containing both wild-
type and inverted sites, which is consistent with fast intramolecular exchange. A similar comparison for Phe106 (right panel) shows marked broadening of
the intramolecular crosspeaks consistent with intermediate exchange on the NMR timescale which likely reflects line-broadening from additional internal
dynamic motions. Incorporating a single-strand defect does significantly alter rapid intramolecular exchange. (c) In contrast, increasing NaCl concentration
accelerates both intermolecular and intramolecular exchange. The two separate peaks reflective of intermolecular exchange (red) for both Arg105 (upper
panels) and Phe106 (lower panels) coalesce into a single peak with increasing NaCl concentration. This change indicates that the intermolecular exchange
rate has increased from the slow to fast NMR timescale. Likewise the crosspeaks reflective of intramolecular exchange (blue and green) sharpen with
increasing NaCl concentration, which is consistent with accelerated intramolecular exchange. For comparison, 2D1H-15N TROSY HSQC spectra of
MBD4MBD bound to methylated wild-type (gray) and inverted (purple) DNA are shown at 100 mM NaCl.
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within the context of the 30 bp DNA, these findings indicate
rapid exchange between the two binding sites. Hence the po-
sition of the crosspeak reflects a weighted average for the
two binding modes, which suggests that MBD4MBD slightly
favors binding to the inverted sequence, spending ∼62% of
time on that site. The crosspeak for Phe106 is not observed
in the 30 bp complex likely reflecting additional internal dy-
namic motions leading to significant line broadening. To-
gether these results show that MBD4MBD exchanges more
efficiently between binding sites in the same molecule con-
sistent with rapid facilitated diffusion along the DNA.
Rapid intramolecular exchange does not require continuous
double-stranded DNA
To test whether a defect in the DNA can impact rapid
intramolecular exchange by MBD4MBD, we introduced
a two-base stretch of single-stranded DNA between the
mCpG binding sites (Table 1). A 2D TROSY 15N-HSQC of
MBD4MBD bound to the 30 bp nicked tandem DNA (Fig-
ure 5b, green) shows similar fast exchange peaks as seen
for the 30 bp tandem DNA complex. Adding a small de-
fect in double stranded DNA does not impede rapid in-
tramolecular exchange of MBD4MBD. This data indicate
that MBD4MBD does not necessarily maintain continuous
contact with the major groove of dsDNA during transloca-
tion, consistent with the local hopping mechanism of facil-
itated diffusion (39–43).
Increasing salt concentration accelerates both intermolecular
and intramolecular exchange by MBD4MBD
Intermolecular exchange rates for protein–DNA complexes
often show a strong dependence on NaCl concentration
(44). Therefore we evaluated the effect of increasing NaCl
concentrations on exchange rates for MBD4MBD when
bound to (i) 1:1 mixture of wild-type and inverted DNA, (ii)
30 bp tandem DNA and (iii) 30 bp nicked tandem DNA. At
very low salt concentrations, Arg105 (Figure 5c, top panel)
shows slow intermolecular exchange and rapid intramolec-
ular exchange as described above. With increasing concen-
trations of NaCl, the intramolecular peaks for Arg105 be-
come sharper (blue and green) indicating an increase in
exchange rate. Concomitantly the intermolecular exchange
peaks for Arg105 (red) undergo profound changes such that
the two peaks observed at low salt concentrations (slow
exchange) merge into one peak (fast exchange) at an av-
erage chemical shift. Likewise, Phe106 (Figure 5c, bottom
panel) shows slow intermolecular exchange and marked
line broadening indicative of intermediate intramolecular
exchange at low salt concentrations. With increasing con-
centrations of NaCl the intramolecular exchange peak for
Phe106 sharpens and becomes detectable (blue and green)
consistent with a transition from intermediate to fast ex-
change on the NMR timescale. At 100 mM NaCl concen-
tration, the crosspeaks for the individual wild-type (gray,
Figure 5c) and inverted DNA (purple, Figure 5c) complexes
remain well separated while the intermolecular exchange
peaks (red) collapse into a single peak indicating fast ex-
change. Importantly, these changes in intramolecular ex-
change kinetics are similar whether the DNA has a 2 bp
defect or not (Figure 5c, green).
Although at 100 mM NaCl both exchange rates fall
within the fast exchange time regime, the linewidths indi-
cate that the intramolecular exchange rate remains much
faster than the intermolecular exchange rate. As can be
seen in Figure 5c and Supplementary Figure S3, the in-
termolecular exchange peaks (red) are much broader, es-
pecially in the 15N dimension, than the intramolecular ex-
change peaks (blue and green). The 15N linewidths at half-
height for intramolecular exchange are 16.7 Hz (Arg105) and
25.0 Hz (Phe106) and for intermolecular exchange are 25.5
Hz (Arg105) and 34.2 Hz (Phe106) (Supplementary Figure
S3), even though the molecular weight of MBD4MBD bound
to the 30 bp tandem DNA (26 551 g/mol) is nearly double
that of MBD4MBD bound to either the wild-type or inverted
DNA sequences (14 159 g/mol).
For comparison, we measured intermolecular exchange
kinetics for cMBD2MBD binding to the same DNA (Fig-
ure 6a). Consistent with an increased binding affinity, the
mean lifetime for intermolecular exchange of cMBD2MBD
is somewhat longer at similar protein concentrations ( ∼66
ms, 185 M protein;  ∼34 ms, 370 M protein). Spec-
tra of cMBD2MBD bound to 20 and 30 bp tandem mCpG
sequences (Figure 6b) show that intramolecular exchange
changes from fast to slow exchange with a small increase
in binding site separation. Hence cMBD2MBD does not ex-
change between binding sites as efficiently as MBD4MBD.
DISCUSSION
MBD4 occupies a unique niche within the MBD family of
proteins. It is the only member of this family that incor-
porates enzymatic activity within the same protein, con-
tributes directly to DNA mismatch repair and does not
specifically recruit histone deacetylase activity. The obser-
vation that the MBD4GD can recognize and repair mis-
match in isolation raises questions about the functional
role of the MBD4MBD. Two alternative, yet not mutually
exclusive, models of MBD4MBD can be proposed: (i) the
MBD4MBD bind to the same site as the MBDGD and thereby
augment sequence specificity or enzymatic activity; or (ii)
the MBD4MBD could target the protein to regions enriched
for mCpG and by virtue of the long intervening linker al-
low the MBD4GD to identify and repair nearby mismatches.
Our recent work on the dynamic distribution of MBD3
on DNA (16) suggests that a similar dynamic behavior of
MBD4MBD would augment the scanning mechanism inher-
ent in the second model of MBD4MBD function. Hence we
studied the structure and dynamics of this protein on DNA.
The basic structural motifs and DNA binding interface
of MBD4MBD are very similar to other MBDs, yet local
structural differences modify binding specificity and affin-
ity. Changing a single tyrosine to phenylalanine at the DNA
interface in MBD3MBD dramatically reduces methylation
selectivity and overall binding affinity. This same tyrosine
in MBD4MBD (Tyr109) changes orientation with respect
to the DNA which correlates with reduced selectivity for
mCpG. Binding analyses by surface plasmon resonance re-
veals a relatively low overall affinity for methylated DNA
and only a modest preference for symmetrically methylated
CpG over mCpG/TpG mismatch, hydroxymethlyated and
unmethylated DNA. Consistent with the reorientation of
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Figure 6. cMBD2MBD does not exchange between binding sites as efficiently as MBD4MBD. (a) The intensities for auto (AA and BB) and exchange (AB
and BA) crosspeaks for Glu21 from Nz-exchange spectra were fit to four coupled equations to determine the rate of intermolecular exchange at 185 M
(upper panel) and 370 M (lower panel) cMBD2MBD concentration. (b) 2D 1H-15N TROSY HSQC spectra of cMBD2MBD bound to methylated wild-
type and inverted (10 bp) DNA (red, upper panel), tandem (30 bp) DNA (blue, middle panel) and tandem (20 bp) DNA (orange, lower panel) show that
intramolecular exchange for cMBD2MBD remains in the slow to intermediate NMR timescale when bound to the tandem (30 bp) DNA. If the sites are 4
bp closer together as in the tandem (20 bp), then cMBD2MBD exchanges between sites on the fast NMR timescale.
Tyr109 away from DNA, the Y109F mutation does not ap-
preciably alter binding affinity and selectivity. The same mu-
tation in cMBD2 reduced binding affinity by ∼50-fold. The
structural rearrangement of Tyr109 places MBD4MBD be-
tween the highly mCpG selective MBD2MBD and the min-
imally mCpG selective MBD3MBD.
As demonstrated by the crystal structures of mouse,
MBD4MBD bound to a variety of modified substrates (31), a
solvent filled protein–DNA interface allows MBD4MBD to
adapt to different binding sites. We hypothesized that this
adaptability and limited selectivity would promote efficient
exchange between mCpG along the same DNA molecule.
This hypothesis arises from the well-established model of
facilitated diffusion by which DNA binding proteins use
one-dimensional diffusion along the DNA to more rapidly
identify a specific binding site (39). In Figure 7, a diagram
depicting facilitated diffusion shows the different modes of
exchange between DNA binding sites which include: (i) sim-
ple 3D diffusion through bulk solvent, (ii) jumping between
nearby strands of DNA; (iii) sliding along the DNA be-
tween sites; and (iv) local hopping which does not required
continuous contact with the DNA.
To study intermolecular and intramolecular exchange for
MBD4MBD, we took advantage of a previous observation
that inverting the central 4 bp of the target DNA leads
to chemical shift changes for select residues (11). Based
on this observation, we used NMR spectroscopy to mea-
sure exchange between binding sites as described for other
transcription factors (29,45–47). Following the peaks for
these residues allowed us to measure the mean lifetime for
intermolecular exchange ( ∼40 ms at 200 M protein)


















Figure 7. A diagram depicting a model of MBD4MBD function in which
rapid intramolecular exchange allows MBD4 to efficiently scan CpG is-
lands for mCpG/TpG mismatches. The left side of the diagram shows the
different modes of searching for binding sites by transcription factors. The
transcription factor (light blue circle) can search for binding sites by dif-
fusion through bulk solvent (3D diffusion) or by different modes of fa-
cilitated diffusion (1D diffusion) including long-range jumps, local hops
and sliding. The right side of the diagram shows the MBD4MBD (blue cir-
cle) exchanging between methylated (red ovals) and unmethylated CpG
sites (black marks). Intramolecular exchange involves local hops that al-
low MBD4 to navigate around obstacles. The tethered MBD4GD (blue
oval) identifies and repairs nearby mCpG/TpG mismatches (blue oval). In
this manner, the MBD4MBD facilitates identification of mCpG/TpG mis-
matches within regions of increased CpG content.
sites in the same molecule of dsDNA occurs on the fast
exchange timescale which indicates that the mean lifetime
is much less than the difference in chemical shift for the
two states ( << ) (30). Hence, the mean lifetime can
be estimated to be < 2 ms, which is at least a 20-fold in-
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crease in rate for intramolecular as compared to intermolec-
ular exchange. Introducing a small stretch of single stranded
DNA does not significantly reduce the intramolecular ex-
change rate. However, raising the NaCl concentration does
increase both intermolecular and intramolecular exchange
rates. Together, these data show that MBD4MBD efficiently
exchanges between binding sites along the DNA and sug-
gest that a local hopping mechanism contributes to the ex-
change process. It would be interesting to test whether ef-
ficient intramolecular exchange by MBD4 can be detected
on a longer length scale using alternative approaches such
as single molecule fluorescence measurements.
Small changes in the protein–DNA binding interface al-
low MBD4MBD to exchange more efficiently between suc-
cessive binding sites along the same DNA molecule. This
intramolecular exchange appears to involve a local hop-
ping mechanism, which would allow MBD4MBD to avoid
obstacles such as other DNA binding proteins on the DNA.
This attribute is consistent with a model of MBD4MBD func-
tion in which the MBD targets the protein to regions of in-
creased mCpG density and allows the glycosylase domain to
scan nearby sites for mCpG/TpG mismatches. The disorder
prediction algorithm PONDR R© VLXT (48,49) indicates
that the majority of the ∼280 amino acid linker separat-
ing the MBD4MBD and MBD4GD is disordered in solution
(Supplementary Figure S4). The average end-to-end length
of a 280 amino acid unstructured polypeptide is approxi-
mately 190 Å (as calculated from (C∞nl2)1/2 where C∞ is
the limiting characteristic ratio (9.27), n is the number of
residues and l the average C-C distance (3.8 Å)) (50,51).
With this long linker, the two domains can span at least 50
bp (3.4 Å rise in B-DNA), which will contain many CpG
dinucleotides in a CpG island. This arrangement allows the
two domains to occupy distinct sites in the DNA such that
the MBD could scan along the same molecule of DNA or
hop between neighboring strands and thereby function to
keep the protein in regions of increased mCpG density when
the MBDGD transiently diffuses off of the DNA.
In Figure 7, a diagram of this model depicts the
MBD4MBD and MBD4GD as blue circle and oval, respec-
tively, separated by a long linker. The MBD4MBD binds
to DNA and exchanges among the different methylated
(red circles), unmethylated (no circle) and mCpG/TpG
mismatch (blue circle) sites. The exchange process is
depicted as a combination of sliding local hopping events
that avoids a protein obstacle while the MBD4GD identifies
and repairs a nearby mCpG/TpG mismatch. This model
helps explain why the MBD4MBD appears to impede (not
augment) enzymatic activity when using a small synthetic
oligonucleotide with a single T-G mismatch (4). The
MBD4MBD competes with MBD4GD when there is only a
single binding site in the substrate. In contrast, full-length
MBD4 shows increased activity when a large nucleosome
substrate with a single T-G mismatch is methylated and
in the presence of competing unmethylated DNA (52).
Hence the MBD4MBD helps localize the enzyme to methy-
lated regions when there is a large amount of competing
unmethylated DNA but does not augment activity on
isolated mismatches. Since a T-G mismatch arises from
spontaneous deamination of methyl-cytosine, preferential
localization to methylated regions would increase the
likelihood that MBD4 would rapidly identify a newly
formed mismatch. The ultimate test of this model will
require comparing the rate at which spontaneous C to T
point mutations arise and the location of these mutations
in cell lines or whole animals with and without MBD4
or with a truncated MBD4 that lacks the MBD4MBD.
In summary, the studies presented here show how a sub-
tle structural rearrangement, one that is not readily identi-
fied by primary sequence analysis alone, can lead to func-
tional differences and specialization within the MBD family
of proteins
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